Quebec Research Offers Hope for Childhood Cancer Therapy

Researchers from McGill University Health Centre (MUHC) and Baylor College of Medicine discovered a potential therapy pathway for the rare and deadly pediatric brain tumor known as Posterior Fossa Group A (PFA) ependymoma. This type of cancer has a high recurrence rate and poor prognosis in children. The study identified unique genomic interactions specific to PFAs, termed TULIPs (Type B Ultra-Long Interactions in PFAs), which could be targeted to improve treatment outcomes. Clinical trials may follow in a year or two pending further validation.